Top
image credit: Unsplash

US plans trial of Gilead coronavirus drug remdesivir

February 25, 2020

Via: CNBC
Category:

The U.S. is planning a clinical trial of Gilead’s experimental drug for the novel coronavirus, according to a posting on a government clinical trials database.

The trial, run by the University of Nebraska Medical Center along with the National Institute of Allergy and Infectious Diseases, will be conducted at up to 50 sites globally, and will test the medicine, called remdesivir, against placebo, according to the protocol, which was posted Feb. 21. The site also notes that, as of then, the trial was not yet recruiting patients.

Read More on CNBC